Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

September 13, 2020

A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

Journal of the American Society of Nephrology : JASN
Nigel D ToussaintIMPROVE-CKD Trial Investigators
September 15, 2020

A short review: Doxorubicin and its effect on cardiac proteins

Journal of Cellular Biochemistry
Shishir UpadhyayMonisha Dhiman
September 17, 2020

Increased Expression Level of Long Noncoding RNA H19 in Plasma of Patients with Myocardial Infarction

International Journal of Molecular and Cellular Medicine
Shokouh SafaeiSeyed Masoud Seyedian
September 17, 2020
Open Access

The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers

International Journal of Molecular Sciences
Ferdinando BarrettaCristina Mazzaccara
September 16, 2020

Recent advances in micro- and nano-bubbles for atherosclerosis applications

Biomaterials Science
Andy WijayaGuixue Wang
September 14, 2020

Methanol extract of Caesalpinia benthamiana normalizes blood pressure and attenuates oxidative stress in uninephrectomized hypertensive rats

Journal of Basic and Clinical Physiology and Pharmacology
Idayat Titilayo GbadamosiOluwafemi Omoniyi Oguntibeju
September 18, 2020

Characterization of Long Non-coding RNA Signatures of Intracranial Aneurysm in Circulating Whole Blood

Molecular Diagnosis & Therapy
Vincent M TutinoJames N Jarvis
September 15, 2020
Open Access

Intermittent Hypoxic Exposure Reduces Endothelial Dysfunction

BioMed Research International
Agnieszka Zembron-LacnyMiłosz Czuba
September 16, 2020
Comment / Editorial
Open Access

Cardiovascular Risk in Children: Focus on Pathophysiological Aspects

International Journal of Molecular Sciences
Simonetta Genovesi, Gianfranco Parati
September 18, 2020

Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Sheng LiuLixin Cheng
September 15, 2020

COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment and follow up

Expert Review of Anti-infective Therapy
Amir TajbakhshAmirhossein Sahebkar
September 15, 2020

Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis

American Journal of Cardiovascular Disease
Yaser S KhalidAdam Levine
September 14, 2020
Open Access

Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes

Cardiovascular Diabetology
Pham Viet ThaiPaul Valensi
September 18, 2020

Role of Thyroid Hormone and Oxidant Stress in Cardiovascular Diseases

Endocrine, Metabolic & Immune Disorders Drug Targets
Mobidullah KhanSmarajit Maiti
September 18, 2020
Open Access

Effects of Smoking and Smoking Cessation on the Intestinal Microbiota

Journal of Clinical Medicine
Marcus G SubletteJames H Stein
September 14, 2020
Open Access

Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19

The Journal of Allergy and Clinical Immunology
Jonathan T SimsJustin Stebbing

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved